Why lipoprotein(a) matters for clinical decisions and patient risk? - report from ACC.25

from Medical Digest & Congress Report · host Medical Congress News

Martha Gulati shares her insights on lipoprotein(a) and atherosclerotic cardiovascular disease at the American College of Cardiology’s Annual Scientific Session. She discussed studies such as HORIZON and the ALPACA trial.Video: https://medicaldigest.org/scientific-contents/interview:why-lipoprotein-matters-clinical-decisions-and-patient-risk

Episode metadata supplied by the publisher feed · Published Apr 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Why lipoprotein(a) matters for clinical decisions and patient risk? - report from ACC.25

0:00 6:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 6 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on April 9, 2025.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!